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Abstract
Objectives: To study the impact of eating disorders (EDs) on the severity of bipolar disorder 
(BD). Methods: The Structured Clinical Interview for DSM-IV Axis I (SCID-I), Young Mania Rating 
Scale (YMRS), Hamilton Depression Rating Scale (HAM-D-17), Hamilton Anxiety Rating Scale 
(HAM-A), Global Assessment of Functioning (GAF), Clinical Global Impression (CGI), and the 
World Health Organization Quality of Life Assessment (WHOQOL-BREF) were used. Clinical and 
sociodemographic data were also collected. Results: Among the 356 bipolar patients included 
in this study, 19 (5.3%) were also diagnosed with ED. Of these, 57.9% had bulimia nervosa (BN) 
and 42.1% had anorexia nervosa (AN). Among ED patients, 94.7% were female. Bipolar patients 
with EDs presented with lower scores in the mental health domain of the WHOQOL-BREF, higher 
scores of depressive symptoms, and more psychiatric comorbidities. Conclusions: ED comorbidities 
imposed important negative outcomes in bipolar patients. This finding suggests that attention 
should be given to the presence of EDs in BD patients and that better treatments focused on this 
population should be developed. 
©2012 Elsevier Editora Ltda. 
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Prevalência e impacto clínico dos transtornos alimentares sobre os pacientes 
bipolares
Resumo
Objetivo: Estudar a influência dos transtornos alimentares (TA) na gravidade do transtorno 
bipolar (TB). Métodos: Foram utilizadas a Entrevista Clínica Estruturada para o Eixo I do DSM-IV 
(SCID-I), a Escala de Young para Avaliação da Mania (YMRS), a Escala de Hamilton para Avaliação 
da Depressão (HAM-D-17), a Escala de Hamilton para Avaliação da Ansiedade (HAM-A), a 
Avaliação do Funcionamento Global (GAF) e a Escala Breve de Avaliação da Qualidade de Vida da 
Organização Mundial da Saúde (WHOQOL-BREF). Os dados clínicos e sociodemográficos também 
foram coletados. Resultados: Entre os 355 pacientes com TB incluídos neste estudo, 19 (5,3%) 
também foram diagnosticados como portadores de TA. Destes, 57,9% tinham bulimia nervosa (BN) 
e 42,1% anorexia nervosa (AN). Dentre os pacientes com TA, 94,7% eram do gênero feminino. Os 
pacientes portadores de TB e TA apresentaram escores mais baixos do domínio saúde mental da 
WHOQOL-BREF, escores mais elevados de sintomas depressivos e mais comorbidades psiquiátricas. 
Conclusões: A presença de comorbidades com TA acarreta importantes desfechos negativos em 
pacientes bipolares. Este achado sugere que atenção deva ser dada à presença de TA em pacientes 
com TB e que melhores tratamentos focados nessa população sejam desenvolvidos.
©2012 Elsevier Editora Ltda. Todos os direitos reservados.
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Introduction
Bipolar disorder (BD) is a serious illness1 in which patients alter-
nate between periods of depression and mania. This disorder 
has a worldwide prevalence ranging from 0.6% to 1.6% in the 
general population,2 and it significantly compromises the social 
and work lives of affected subjects.3 BD is frequently associ-
ated with comorbidities, which are primarily anxiety disorders, 
alcohol and drug abuse, and dependency, as well as eating 
disorders (EDs).4 In a review of studies conducted between 1982 
and 2003,5 the prevalence of EDs in BD patients (2.3% to 15%) 
was higher than that in the general population (0.7% to 1.8%).
Brietzke et al.6 studied 137 women with type I BD us-
ing the Structured Clinical Interview for the Diagnostic 
and Statistical Manual of Mental Disorders, Axis I Disorders 
(SCID-I), and a sociodemographic questionnaire, and found 
a 14.6% prevalence of EDs. In this study, patients with EDs 
had an earlier onset of BD; more depressive episodes; more 
comorbidities, especially with substance use and anxiety 
disorders; and a higher number of suicide attempts.
Also, recently, McElroy et al.7 investigated the prevalence and 
clinical characteristics of 875 type I and II bipolar patients with 
EDs, and showed a prevalence of 14.3%. In this study, the pres-
ence of EDs in patients with BD was associated with earlier onset 
of mood disorder; presence of mixed episodes and rapid cycling; 
presence of severe mood episodes; and history of suicide at-
tempts, obesity, and comorbidity with alcoholism and drug abuse.
Thus, to the best of our knowledge, only few studies have ex-
plored the prevalence of EDs in BD patients, investigated the con-
sequences of this comorbidity on quality of life, and described the 
characteristics of BD patients with and without EDs. Therefore, 
the present study aimed to assess whether several demographic 
and clinical variables were associated with the presence of EDs 
in BD patients, and to study the impact of EDs on the severity of 
bipolar disorder patients in a selected Brazilian sample. 
Methods
All patients diagnosed with BD and who had undergone 
treatment between March 31, 2005, and March 22, 2009, at 
two university hospitals in Salvador and Porto Alegre, Brazil, 
were included 
All patients were 18 years of age or older and presented 
with mood symptoms of varying severity (in acute phase or 
not). Patients with mental disturbances who were unable 
to understand the study and those who refused to sign the 
informed consent form were excluded. 
Subjects were submitted to the following assessments: 
clinical and sociodemographic questionnaire, Structured 
Clinical Interview for DSM-IV Axis I (SCID-I), Young Mania 
Rating Scale (YMRS), Hamilton Depression Rating Scale 
(HAM-D-17), Hamilton Anxiety Rating Scale (HAM-A), Global 
Assessment of Functioning (GAF), and Clinical Global 
Impression Scale (CGI). The World Health Organization 
Rating Scale for quality of life evaluation (WHOQOL-BREF) 
was used in a subsample (n = 180) of participants. The 
interviews were conducted by researchers who had for-
mal training and extensive experience in dealing with all 
instruments.
The Statistical Package for Social Sciences (SPSS) 
software, version 13.0, was used for statistical analyses. 
Mean and standard deviations were estimated for continu-
ous variables. For categorical variables, either Pearson’s 
chi-square test or Fisher’s exact test were used, and the 
Mann-Whitney U test was applied for continuous vari-
ables. Binary logistic regression analyses were conducted 
to assess the contribution of each predictor variable 
independently, and those with p < 0.10 were included in 
the equation. A significance level of 0.05 was used for all 
statistical analyses.
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Results
A total of 406 bipolar patients were initially selected. Fifty 
(12.3%) patients were excluded due to data loss. A total of 
356 (87.7%) patients were assessed.
Among the 356 bipolar patients included in this study, 
5.3% (n = 19) had an ED diagnosis, current or lifetime. Of 
these, 57.9% (n = 11) had bulimia nervosa (BN) and 42.1% 
(n = 8) had anorexia nervosa (AN). The mean age of our 
sample was 41.4 years. There were significant differences 
among BD patients with and without EDs, and EDs group had 
a higher number of females. The only male participant met 
the diagnostic criteria for BN.
No significant differences were found in the CGI, GAF, HAM-A, 
and YMRS scores between subjects with and without EDs. There 
was a trend for patients with EDs to present higher HAM-A scores 
(p = 0.07), and HAM-D-17 scores were higher in patients with EDs 
compared to those without EDs (p = 0.01, Table 1).
In the logistic regression conducted to assess if demo-
graphic and clinical variables significantly predicted whether 
participants had or not EDs, 57 of the 406 participants had 
missing data and were not considered in the analysis. Variables 
whose significance was p < 0.10 [gender (p = 0.02), ethnicity 
(p = 0.06), marital status (p = 0.08), HAM-D (0.06), and number 
of comorbidities (p < 0.001)] were included in the equation. In 
this analysis, only gender and number of comorbidities were 
individually significant regarding EDs. Nevertheless, the overall 
model was significant when all five independent variables were 
included (χ2 = 38.71, df = 5, n = 349, p < 0.001). Taken to-
gether, gender (OR = 0.61, p = 0.02), marital status (OR = 0.50, 
p = 0.03), and number of comorbidities (OR = 1.68, p < 0.001) 
were significant predictors, but not ethnicity (OR = 0.33, 
p = 0.13) and HAM-D (OR = 0.99, p = 0.79). These odds ratios 
suggest that the odds of having EDs are increasingly greater 
as the number of comorbidities increases and as the number 
of male and participants having partners decreases.
A subsample of BD patients in this study provided 
quality of life information by completing the WHOQOL-
BREF (n = 180). Of these, only 14 had EDs. We repli-
cated the same analysis with this smaller sample and 
included the psychological domain of the WHOQOL-BREF, 
the only quality of life domain independently significant 
Table 1  Demographic and clinical features for 356 bipolar patients with and without lifetime comorbid eating disorders
Variable* No eating disorder
(n = 337)
Eating disorder
(n = 19)
p
Gender, No. (%) 
Female 231 (68.8) 18 (94.7) 0.02
Age, mean (SD)
Current 41.6 (12.1) 40.4 (11.1) 0.70
At first episode 26.3 (12.5) 21.7 (10.7) 0.11
At diagnosis 34.5 (12.2) 30.9 (10.9) 0.31
Marital status, No. (%)
Married/living with partner 120 (36.2) 4 (21.1) 0.21
Single/divorced/widow 212 (63.8) 15 (78.9)
Occupation, No. (%)
Employed 82 (24.6) 5 (26.3)
Student/homemaker/retired/sick-leave) 251 (75.4) 14 (73.7) 0.79
Type of first episode, No. (%)
Mania/hypomania 124 (55.1) 8 (57.1)
Depression 72 (32.0) 2 (14.3) 0.16
Mixed  29 (12.9) 4 (28.6)
Hospitalizations, No. (%) 263 (79.9) 16 (88.9) 0.54
Rapid cycling, No. (%) 63 (19.7) 6 (33.3) 0.22
Suicide attempts, No. (%) 138 (42.5) 11 (61.1) 0.12
Number of comorbidities, mean (SD) 2.4 (2.0) 4.7 (1.9) 0.0001
CGI, mean (SD) 3.1 (1.8) 3.6 (1.2) 0.22
HAM-A, mean (SD) 10.5 (8.8) 13.6 (7.6) 0.07
HAM-D, mean (SD) 8.4 (7.7) 11.7 (6.0) 0.01
GAF, mean (SD) 59.5 (18.4) 55.8 (12.7) 0.16
WHOQOL-BREF,** mean (SD)
Physical health 53.1 (19.9) 45.2 (23.5) 0.19
Psychological health 52.9 (20.8) 34.9 (14.7) 0.001
Social relations 53.2 (23.2) 46.4 (18.7) 0.21
Environment 55.1 (15.9) 50.0 (11.3) 0.10
SD: standard deviation; CGI: Clinical Global Impression; HAM-A: Hamilton Anxiety Scale; HAM-D: Hamilton Depression Scale; YMRS: Young Mania Rating 
Scale; GAF: Global Assessment of Functioning; WHOQOL: World Health Organization Quality of Life. 
*Not all sample sizes are n = 337 because of missing data; **n = 180.
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associated with EDs (p = 0.002). The number of comor-
bidities was also independently significant regarding EDs 
(p = 0.01), but not ethnicity (p = 0.80), marital status 
(p = 0.17), and HAMD (p = 0.72). In this smaller sample, 
there was a trend for gender to reach significance 
(p = 0.06). When all six predictors were considered to-
gether in the equation, they significantly predicted EDs 
(χ2 = 24.57, df = 6, n = 180, p < 0.001). Nonetheless, only 
number of comorbidities (OR = 1.37, p = 0.05), HAM-D 
(OR = 0.89, p = 0.04) and the psychological domain of 
WHOQOL-BREF (OR = 0.67, p = 0.004) were significantly 
associated with EDs. There was a trend for marital status 
(OR = 0.52, p = 0.07) to reach significance. Here, the odds 
ratios suggest that the odds of having EDs are increasingly 
greater as the number of comorbidities increase and HAM-D 
and quality of life (psychological domain) scores decrease.
Discussion
The present study found a prevalence of EDs in BD patients 
that is similar to that commonly seen in the literature,8 which 
is higher than that found in the general population.5 Our 
results also corroborate data in the literature that indicate 
a higher prevalence of female patients with EDs.9,10
Also, these BD patients with comorbid EDs had signifi-
cantly more negative clinical outcomes, namely higher scores 
for depressive symptoms as assessed by the HAM-D scale, 
lower scores of quality of life in the psychological domain 
of the WHOQOL-BREF, and significantly more psychiatric 
comorbidities.
EDs have been suggested to occur more frequently in the 
depressive phase,11 and this phenomenon was corroborated 
by our study. This finding may explain, at least partially, 
why quality of life is impaired in these individuals, as QOL 
scores are likely to be markedly lower in BD patients during 
the depressive phase.12 Both HAM-D and the psychological 
domain of the WHOQOL-BREF were significant predictors of 
the ED presence in BD patients when adjusted by the logisti-
cal regression model.
It is worth noting that mood stabilizers, which are the 
first-line treatments of BD patients, lead to weight gain.11 
This effect, by itself, could negatively impact prognosis 
because it reduces treatment adherence in subjects who 
already have an ED.13 These patients, therefore, require 
individualized treatment administered by a multiprofessional 
and well-trained staff.14
Our findings should be interpreted in light of several 
limitations. First, the cross-sectional design used herein 
precluded the opportunity to examine a temporal relation-
ship between BD and ED. Second, this study used a selected 
sample of patients from specialised services; therefore, the 
results may not be generalised to other psychiatric settings 
or to community situations. Third, body mass index (BMI) 
values, which are important information for the appropriate 
analysis of patients with EDs, were not measured. Fourth, 
binge eating disorder, although widely studied, was not 
included in this study because it was not included as a di-
agnostic category by the DSM-IV. Finally, this study included 
only adults and all types of bipolar patients, suggesting that 
further studies should be conducted so that more informa-
tion can be gathered to differentiate bipolar children and 
adolescents with comorbid EDs from the adult population. In 
addition, future studies should investigate the impact of EDs 
in different types of BDs, controlling for different variables.
In summary, this study reports the analysis of a sample 
of BD patients from two Brazilian large cities, confirming 
previous clinical findings of the comorbid current and lifetime 
prevalence of EDs in BD subjects seen in literature. In addi-
tion, individuals with BD and EDs presented with significantly 
more severe BD symptoms than those without EDs. These 
findings suggest the need for differential diagnostic assess-
ments, as well as individualised treatment plans.
Our study encourages further research to elucidate the 
genetic and neurobiological bases of BD and EDs. Moreover, 
prospective studies should be encouraged to better clarify 
the temporal relationship and the prognostic implications of 
comorbid EDs in BD patients.
Conclusions
Our findings suggest that BD patients with comorbid EDs 
experience higher illness severity relative to BD patients 
without EDs. Such findings suggest the need for differentiated 
diagnoses and treatment plans for these patients. However, 
further research is needed to confirm these results and ensure 
that these findings can be generalised for the entire clinical 
population of patients with BD.
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